The Oral Cancer Foundation
Target demographics: While historically the majority of people are over the age of 40 at the time of discovery, oral cancer does occur in those under this age. It is also now confirmed that in a younger age group, including those who have never used tobacco products, have a cause which is HPV viral based. The human papilloma virus, particularly version 16, has now been shown to be sexually transmitted between partners, and is conclusively implicated in the increasing incidence of young non-smoking oral cancer patients.
Geographic areas served: USA
Board Members and Affiliation: Oral Cancer Foundation Science Advisory Board:
Michael C. Alfano, DMD, Ph.D
Former Dean, New York University, College of Dentistry
Executive Vice President, New York University
Kian Ang MD, Ph.D
President, American Society for Therapeutic of Radiology and Oncology
Professor, Radiation Oncology
Gilbert H. Fletcher
Chair MD Anderson Cancer Center
William B. Armstrong, M.D.
Associate Professor of Clinical Otolaryngology &Vice Chair
Department Otolaryngology-Head and Neck Surgery
University of California, Irvine
John Beumer III, DDS, M.S.
Chair and Professor
Division of Advanced Prosthodontics, Biomaterials and Hospital Dentistry
The Weintraub Center for Reconstructive Biotechnology
UCLA School of Dentistry
David L. Callender, MD, MBA, FACS
Former Chief of Medicine, MD Anderson Cancer Center
Associate Vice Chancellor, UCLA Hospital System
Maura L. Gillison, MD, PhD
Jeg Coughlin Chair of Oral Cancer Research
Professor of Internal Medicine & Epidemiology
College of Medicine
The Ohio State University
Jimmie C. Holland, MD
Chair, Psychiatry and Behavioral Sciences
Memorial Sloan-Kettering Cancer Center
Alice Horowitz Ph.D
Senior Scientist
National Institute of Dental Research, National Institutes of Health
Rhonda Jacob DDS, M.S.
President, American Academy of Maxillofacial Prosthetics
President-elect, American Academy of Prosthodontics
Professor of Dental Oncology
Maxillofacial Prosthodontist
Department of Head and Neck Surgery
Section of Oncologic Dentistry and Prosthodontics
University of Texas, M. D. Anderson Cancer Center
Department of Head and Neck Surgery
Ole T. Jensen DDS, M.S.
Board Examiner, American Board of Oral and Maxillofacial Surgery
President, Colorado Society of Oral and Maxillofacial Surgeons
Private practice in oral surgery
A. Ross Kerr DMD
Clinical Associate Professor
Department of Oral Medicine
New York University College of Dentistry
Department of Oral & Maxillofacial Pathology, Radiology & Medicine
Dennis H. Kraus MD
Director, Speech and Hearing Center
Associate Attending Surgeon
Otolaryngology, Head & Neck Surgery
Memorial Sloan-Kettering Cancer Center
Mark W. Lingen DDS, PhD
Associate Professor
Department of Pathology
The University of Chicago
Robert A. Ord M.D., DDS
Chairman, Department of Oral and Maxillofacial Surgery
School of Dentistry, University of Maryland
Nelson Rhodus DMD, MPH
President and Diplomat, American Academy of Oral Medicine
Professor and Director, Division of Oral Medicine, School of Dentistry
Adjunct Professor, Dept. of Otolaryngology, School of Medicine
Academy of Distinguished Teachers
President, American Association of University Professors
University of Minnesota
James J. Sciubba, DMD, PhD
Professor, The Johns Hopkins School of Medicine
Director, Dental and Oral Medicine
Dept of Otolaryngology, Head & Neck Surgery
David Sidransky, M.D.
Director, Head and Neck Cancer Research
Professor, Otolaryngology - Head and Neck
Surgery, Oncology, Pathology, Urology, & Cellular and Molecular Medicine
Division of Head and Neck Cancer Research
Dept. of Otolaryngology
Johns Hopkins University
Sol Silverman Jr. DDS
Professor of Oral Medicine
University of California, San Francisco
Harold Slavkin DDS
Dean, School of Dentistry, University of Southern California
Former Director, The National Institutes of Dental
and Craniofacial Research / National Institutes of Health
David Wong DMD, DMS
Professor, School of Dentistry
Chair, Division of Oral Medicine & Biology
Director, Dental Research Institute
University of California at Los Angeles
Member, Jonsson Comprehensive Cancer Center
Member, Molecular Biology Institute
With our mouth we eat and drink what sustains us. With it, we communicate ideas and feelings to the world through speech or a simple smile. It allows us to taste the nuance of a fine wine, the sweetness of a freshly picked berry, or mustard covered hot dog at the ballpark. Love or passion is expressed by it when we kiss a loved one or child. When cancer affects our mouths, it does more than take away these everyday functions, it too often takes our lives. Through increased public and professional awareness, prevention through lifestyle changes, early detection initiatives, education, improved treatment modalities, and sponsorship of research, the Oral Cancer Foundation’s mission is to contribute to the reduction of suffering, permanent physical damage and disfigurement, and death caused by this disease.
The foundation is an IRS registered non-profit 501(c) 3, public service charity designed for advocacy and service, created to promote change, through proactive means, in both the public and medical/dental professional sectors. At the forefront of our agenda is the firm establishment in the minds of the American public for the need to undergo an annual oral cancer screening, combined with an outreach to the dental and medical communities to provide this service as a matter of routine practice. Oral cancer takes more lives than cancers we routinely hear about, such as cervical, Hodgkin’s lymphoma, skin (malignant melanoma), testicular, and many others. In the efforts to reduce the death rate from cancers in the US, the most significant progress has been made through early detection. Cervical, skin, prostate, and others that lend themselves to simple, opportunistic screenings and exams have all had their death rates reduced through programs promoting early discovery. Early discovery and diagnosis, yields better long-term outcomes, and lower morbidity to those who undergo treatments. Oral cancer is not hidden within the body in some hard to find location requiring an invasive examination, the majority of the time it is literally in plain view, right under your nose, and can be seen with the naked eye or felt with the fingers. In most cases, its early, highly survivable stages are easily detected in a 3 to 5 minute painless visual and tactile examination. Even the precancerous lesions, which can progress into malignancy, can be seen with the naked eye. An annual oral examination conducted by members of the dental and medical communities will have a definite impact on reducing the death rate associated with oral cancer. It is our mission to bring this about.
Founded by an oral cancer survivor, Brian R. Hill, the foundation’s goals are supported by a Scientific Advisory Board composed of leading cancer authorities from varied medical and dental specialties, drawn from premier cancer treatment, research, and educational institutions in the US. The foundation is currently forming its Board of Advisors from a selection of individuals with experience in philanthropic and cause related issues, and continues to add to its board of directors.
In 2008 The Bruce Paltrow fund was added to OCF as a collaborative effort between the Paltrow family, headed by Actress Blythe Danner (Paltrow), and OCF’s founder. The Paltrow fund has specific goals to aid in fund raising and public outreach efforts. The goals reflect the humanitarian nature of Director Producer Bruce Paltrow who was lost to oral cancer in 2002. More details related to this fund’s efforts in areas where disparities in health care exist can be found here.
The foundation is primarily supported by, and dependant on, donations that are received from private individuals who mostly come from the ranks of survivors, and family and friends of those who have had the disease. As a disease that has not received the national publicity and awareness of some of the major cancers such as breast, prostate, etc., national fund raising efforts pale in comparison when support from the general public is considered. A small group of private sector corporate sponsors have also made unrestricted donations to the foundation in support of its efforts. Early funding for some projects was underwritten and paid for privately by Brian and Ingrid Hill, the founders. Brian Hill has also donated without compensation 1000’s of hours of his working time since 2001 to further the work of the foundation. While the foundation has the tax status to receive monies from federal and state governments and institutions, no grant money has been obtained from these sources to date. The foundation hopes to continue to develop relationships with benevolent corporate sponsors or other foundations who share common goals with OCF, which will provide the funding necessary to enact the initiatives that the foundation has pending at this time.
See all »


